A Potent Nonpeptide Antagonist of the Substance P (NK 1 ) Receptor
- 25 January 1991
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 251 (4992) , 435-437
- https://doi.org/10.1126/science.1703323
Abstract
CP-96,345 [(2S, 3S)-cis-2-(diphenylmethyl)-N-[(2-methoxyphenyl)- methyl]-1-azabicyclo[2.2.2]octan-3-amine] is a potent nonpeptide antagonist of the substance P (NK1) receptor. CP-96,345 inhibited 3H-labeled substance P binding and was a classical competitive antagonist in the NK1 monoreceptor dog carotid artery preparation. CP-96,345 inhibited substance P-induced salivation in the rat, a classical in vivo bioassay, but did not inhibit NK2, NK3, or numerous other receptors; it is thus a selective NK1 antagonist. This compound may prove to be a powerful tool for investigation of the physiological properties of substance P and exploration of its role in diseases.Keywords
This publication has 24 references indexed in Scilit:
- Substance P primes human neutrophil activation: A mechanism for neurological regulation of inflammationBiochemical and Biophysical Research Communications, 1989
- New selective agonists for neurokinin receptors: pharmacological tools for receptor characterizationTrends in Pharmacological Sciences, 1988
- Substance P Activation of Rheumatoid Synoviocytes: Neural Pathway in Pathogenesis of ArthritisScience, 1987
- Substance P recognition by a subset of human T lymphocytes.Journal of Clinical Investigation, 1984
- Correlation between inositol phospholipid hydrolysis and substance P receptors in rat CNSNature, 1984
- Substance P as a Transmitter CandidateAnnual Review of Neuroscience, 1980
- Effect of Substance P on Blood Flow in Canine Adipose Tissue and Skeletal MuscleActa Physiologica Scandinavica, 1975
- Quinuclidine chemistry. 2. Synthesis and antiinflammatory properties of 2-substituted benzhydryl-3-quinuclidinolsJournal of Medicinal Chemistry, 1974
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973
- SYMPOSIUM on the Physiology and Pharmacology of Receptors and Nerve Endings held at Stockholm December 5th‐6th 1952Acta Physiologica Scandinavica, 1953